- India and Russia will drive Dr Reddy’s growth : Dr K Anji Reddy
India and Russia will drive growth for Dr Reddy’s Laboratories in the coming years, Dr K Anji Reddy told shareholders.
- Dr Reddy's aim at $1 bn revenue per year in next 3 years
Pharma major Dr Reddy's Laboratories aims to earn revenue of $ 1 billion per year from branded generics for the next three years, said K. A...
- Gas leak at Dr Reddy's unit claims two lives
The USFDA-approved facility, located in Bollaram in Medak district on the outskirts of Hyderabad, manufactures active pharmaceutical ingred...
- Pharma growth slows down to 9.6%
Growth in the domestic pharma market dipped in September over the previous month, but was still nearly double digit at 9.6%.
- Analyst's Pick: Dr Reddy's Laboratories
Citigroup recommends 'Hold' rating on Dr Reddy’s Laboratories with a target price of Rs 547.
- Dr Reddy's commences operations in Philippines
India's drug maker Dr Reddy's Laboratories Ltd today said it has opened a new office in Manila, Philippines in partnership with Britton Mar...
- Dr Reddy's eyes US firm Bradley
If the deal goes through, it will help Dr Reddy’s expand its branded formulations portfolio & save the company the hassle of getting separa...
- Dr Reddy's to tap Nigerian Pharma market
Pharma major Dr Reddys Laboratories Ltd on Friday said it has inaugurated its Nigerian operations in partnership with Nairobi-based Phillip...
- DRL, Torrent Pharma ink deal to tap Russian mkt
Pharmaceutical major, Dr Reddy’s Laboratories Ltd (DRL) and Torrent Pharmaceuticals Ltd on Wednesday concluded an agreement for exclusive c...